Fibronectin 1 serves as a potential diagnostic, immunological and prognostic biomarker for glioblastoma patients

被引：0
|
作者：
Shen, Ao [1 ]
Dai, Lirui [1 ]
Zhou, Dongjie [1 ]
Zhou, Peizhi [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2025年 / 48卷 / 03期
关键词：
Glioblastoma multiforme; Fibronectin; 1; Biomarkers; Prognosis; Immune regulation;
D O I：
10.1016/j.asjsur.2024.09.186
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：2091 / 2092
页数：2
相关论文
共 50 条
  • [21] Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma
    Kwon, Hyukjun
    Yun, Minji
    Kwon, Taek-Hyun
    Bang, Minji
    Lee, Jungsul
    Lee, Yeo Song
    Ko, Hae Young
    Chong, Kyuha
    BIOMEDICINES, 2023, 11 (12)
  • [22] PVR(CD155) as a potential immunological, diagnostic, and prognostic biomarker for pancreatic adenocarcinoma
    He, Feng
    Zhao, Zishan
    Li, Qingyun
    Li, Bo
    ASIAN JOURNAL OF SURGERY, 2024, 47 (10) : 4409 - 4411
  • [23] PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
    Ding, Na
    Li, Meiping
    Zhao, Xiaokun
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [24] MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
    Dengwang Chen
    Na Zhong
    Zhanwen Guo
    Qinglu Ji
    Zixuan Dong
    Jishan Zheng
    Yunyan Ma
    Jidong Zhang
    Yuqi He
    Tao Song
    Scientific Reports, 13
  • [25] MCM10, a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
    Chen, Dengwang
    Zhong, Na
    Guo, Zhanwen
    Ji, Qinglu
    Dong, Zixuan
    Zheng, Jishan
    Ma, Yunyan
    Zhang, Jidong
    He, Yuqi
    Song, Tao
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [26] PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer
    Na Ding
    Meiping Li
    Xiaokun Zhao
    Scientific Reports, 13
  • [27] GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
    Chen, Guoming
    Luo, Dongqiang
    Zhong, Nan
    Li, Danyun
    Zheng, Jiyuan
    Liao, Hui
    Li, Zhuoyao
    Lin, Xiaoxiao
    Chen, Qiqi
    Zhang, Cheng
    Lu, Yuanjun
    Chan, Yau-Tuen
    Ren, Qing
    Wang, Ning
    Feng, Yibin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
    Hu, Hao
    Wang, Zhi-Wen
    Hu, Shuang
    Xiang, Yuan
    Deng, Yang
    Wan, Fu-Jian
    Zhang, Tong-Cun
    Yang, Zhong-Yi
    Liao, Xing-Hua
    ONCOLOGY REPORTS, 2023, 50 (02)
  • [29] Circulating TERT serves as the novel diagnostic and prognostic biomarker for the resectable NSCLC
    Chen, Guanxuan
    Wang, Shiwen
    Zhang, Qianru
    Liu, Junyan
    Zhu, Wanqi
    Song, Xianrang
    Song, Xingguo
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [30] ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
    Jiao, Yan
    Li, Yanqing
    Liu, Songyang
    Chen, Qingmin
    Liu, Yahui
    ONCOTARGETS AND THERAPY, 2019, 12 : 4141 - 4152
12345